CVS Stock Ownership Activity

CVS HEALTH CORP 13F holders

4 value investing gurus have made changes to the CVS HEALTH CORP (CVS) position according to the gurus' latest SEC quarterly report(s). CVS has been completely sold out by 1 guru(s), the number of CVS shares has been increased by 2, decreased by 1 super investor(s).

Which gurus or hedge funds are buying CVS now?

According to the latest SEC filing(s) CVS HEALTH CORP (CVS) has been bought by 2 gurus: V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (added shares +34.59%) and Andrew Brenton - Turtle Creek Asset Management (added shares +0.92%).

To see more about who is investing in CVS HEALTH CORP (CVS), please go to the CVS ownership page.

2024 Q1 (4 results)
V. D. Dodge, E. M. Cox
+34.59%
+7,078,900
+0.52%
2.03%
Andrew Brenton
+0.92%
+15,666
+0.03%
3.34%
Robert Olstein
-9.15%
-13,000
-0.17%
1.68%
Michael Burry
-100.00%
-65,000
-4.96%
0.00%
Current price: $59.99 24.79% AVG reported price*: $79.76
2023 Q4 (6 results)
Michael Burry
buy
+65,000
+5.43%
0.00%
V. D. Dodge, E. M. Cox
+11.58%
+2,123,900
+0.17%
1.65%
David Katz
-2.50%
-500
-0.07%
2.55%
Andrew Brenton
-6.84%
-124,950
-0.26%
3.55%
Robert Olstein
-8.39%
-13,000
-0.17%
1.89%
Bill Gates
-100.00%
-32,500
-0.01%
0.00%
Current price: $59.99 24.02% AVG reported price*: $78.96
2023 Q3 (7 results)
Bill Gates
buy
+32,500
+0.01%
0.00%
Andrew Brenton
+3,527.71%
+1,776,200
+3.54%
3.64%
V. D. Dodge, E. M. Cox
+71.03%
+7,617,500
+0.59%
1.41%
Mark A. Hillman
+26.15%
+17,000
+0.57%
2.74%
Robert Olstein
+12.32%
+17,000
+0.20%
1.86%
Ronald Muhlenkamp
-100.00%
-110,695
-2.64%
0.00%
Michael Burry
-100.00%
-100,000
-15.75%
0.00%
Current price: $59.99 14.08% AVG reported price*: $69.82
2023 Q2 (5 results)
Michael Burry
buy
+100,000
+6.21%
0.00%
Andrew Brenton
+57.59%
+18,400
+0.04%
0.10%
V. D. Dodge, E. M. Cox
+19.17%
+1,725,100
+0.13%
0.81%
Robert Olstein
+16.95%
+20,000
+0.22%
1.54%
Ronald Muhlenkamp
+0.52%
+572
+0.01%
0.00%
Current price: $59.99 13.22% AVG reported price*: $69.13
2023 Q1 (2 results)
Andrew Brenton
+486.24%
+26,500
+0.06%
0.07%
Robert Olstein
+51.28%
+40,000
+0.47%
1.37%
Current price: $59.99 19.27% AVG reported price*: $74.31
2022 Q4 (4 results)
Andrew Brenton
+289.29%
+4,050
+0.01%
0.02%
Robert Olstein
+2.63%
+2,000
+0.03%
1.14%
Ronald Muhlenkamp
+0.11%
+122
+0.00%
4.35%
V. D. Dodge, E. M. Cox
-2.19%
-201,200
-0.02%
0.97%
Current price: $59.99 35.63% AVG reported price*: $93.19
2022 Q3 (4 results)
Andrew Brenton
buy
+1,400
+0.01%
0.01%
Ronald Muhlenkamp
+0.99%
+1,078
+0.05%
4.68%
V. D. Dodge, E. M. Cox
+0.19%
+17,000
+0.00%
1.13%
David Katz
-15.97%
-3,800
-0.74%
3.92%
Current price: $59.99 37.15% AVG reported price*: $95.46
2022 Q2 (4 results)
Ronald Muhlenkamp
-0.10%
-114
-0.00%
4.73%
V. D. Dodge, E. M. Cox
-1.32%
-122,700
-0.01%
1.02%
Robert Olstein
-23.23%
-23,000
-0.32%
1.06%
Prem Watsa
-43.40%
-11,500
-0.04%
0.05%
Current price: $59.99 35.26% AVG reported price*: $92.66
2022 Q1 (4 results)
Ronald Muhlenkamp
+0.37%
+404
+0.01%
3.84%
David Katz
-13.77%
-3,800
-0.58%
3.65%
Mark A. Hillman
-15.58%
-12,000
-0.49%
2.67%
Robert Olstein
-21.43%
-27,000
-0.34%
1.26%
Current price: $59.99 40.73% AVG reported price*: $101.21
2021 Q4 (5 results)
Ronald Muhlenkamp
-0.01%
-12
-0.00%
3.91%
V. D. Dodge, E. M. Cox
-4.43%
-431,000
-0.05%
1.00%
David Katz
-4.83%
-1,400
-0.21%
4.04%
Robert Olstein
-28.81%
-51,000
-0.63%
1.55%
Michael Burry
-100.00%
-200,000
-22.79%
0.00%
Current price: $59.99 41.85% AVG reported price*: $103.16
2021 Q3 (2 results)
Ronald Muhlenkamp
-0.17%
-189
-0.01%
3.54%
Robert Olstein
-1.67%
-3,000
-0.03%
1.84%
Current price: $59.99 29.31% AVG reported price*: $84.86
47 of 143

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.